A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the efficacy and safety of salvage tratment with Gemcitabine and S-1 Combination in metastatic colorectal cancer

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gachon University Gil Medical Center
• Treatments: Gemcitabine

Criteria

Inclusion Criteria:

• non resectable colorectal adenocarcinoma.

• disease progression during or within 6months after treatment with irinotecan and oxaliplatin contaning regimens.

• estimated life expectancy of more than 3 months.

• ECOG status 2 or lower

Exclusion Criteria:

• other tumor type than adenoarcinoma.

• presence or history of CNS metastasis.

• evidence of gastrointestinal bleeding.